Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Defiante Farmacêutica is a Portuguese pharmaceutical company based in Madeira that operates as a key subsidiary within the Alfasigma group (formerly Sigma-Tau). The company focuses on the development, manufacturing, and commercialization of specialized pharmaceutical products, with a historical emphasis on metabolic and endocrine health. It is particularly well-known for its involvement in carnitine-based therapies used to treat primary and secondary carnitine deficiencies. Defiante manages a diverse portfolio of established brands and contributes to the global supply chain of the Alfasigma group through its international distribution and regulatory activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Defiante Farmacêutica.